login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ROYALTY PHARMA PLC- CL A (RPRX) Stock News
NASDAQ:RPRX -
GB00BMVP7Y09
-
Common Stock
35.9
USD
+0.28 (+0.79%)
Last: 8/29/2025, 3:03:08 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RPRX Latest News, Press Relases and Analysis
All
Press Releases
14 days ago - By: Chartmill
Royalty Pharma PLC - Class A (NASDAQ:RPRX) Shows Strong Technical Breakout Potential with High ChartMill Ratings
4 days ago - By: Benzinga
- Mentions:
AMGN
AZN
SMMT
ONC
BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up
4 days ago - By: Yahoo Finance
- Mentions:
AMGN
Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales
4 days ago - By: Royalty Pharma plc
Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
4 days ago - By: Royalty Pharma plc
Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
16 days ago - By: Royalty Pharma plc
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
16 days ago - By: Royalty Pharma plc
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
17 days ago - By: Benzinga
Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today
17 days ago - By: Yahoo Finance
- Mentions:
MS
PFE
Morgan Stanley Maintains a Buy Rating on Royalty Pharma Plc (RPRX) With a $55 PT
23 days ago - By: The Motley Fool
Royalty Pharma (RPRX) Q2 Receipts Up 20%
23 days ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q2 Earnings
23 days ago - By: Zacks Investment Research
- Mentions:
IVVD
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates
23 days ago - By: Royalty Pharma plc
Royalty Pharma Reports Second Quarter 2025 Results
23 days ago - By: Royalty Pharma plc
Royalty Pharma Reports Second Quarter 2025 Results
24 days ago - By: Zacks Investment Research
Countdown to Royalty Pharma (RPRX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
a month ago - By: Yahoo Finance
- Mentions:
MS
Morgan Stanley Raises Royalty Pharma (RPRX) Price Target, Maintains Overweight Rating
a month ago - By: Royalty Pharma plc
Royalty Pharma Declares Third Quarter 2025 Dividend
a month ago - By: Royalty Pharma plc
Royalty Pharma Declares Third Quarter 2025 Dividend
a month ago - By: Royalty Pharma plc
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
a month ago - By: Royalty Pharma plc
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
a month ago - By: Royalty Pharma plc
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
a month ago - By: Royalty Pharma plc
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
2 months ago - By: Royalty Pharma plc
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
2 months ago - By: Royalty Pharma plc
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
Please enable JavaScript to continue using this application.